Expressing support for the designation of September 2023 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

This resolution expresses support for the goals and ideals of Sickle Cell Disease Awareness Month and encourages the President to support access to innovative therapies for the disease. Sickle cell disease is an inherited blood disorder than can lead to pain, anemia, infections, and stroke.

Bill 118 HRES 692, also known as the "Sickle Cell Disease Awareness Month" bill, aims to designate September 2023 as a month dedicated to raising awareness about sickle cell disease in the United States. The bill emphasizes the importance of educating communities about the disease, as well as the need for research, early detection methods, effective treatments, and preventative care programs.

Sickle cell disease is a genetic blood disorder that affects red blood cells, causing them to become rigid and sickle-shaped. This can lead to various complications, such as pain crises, organ damage, and increased risk of infections. The bill highlights the importance of increasing awareness about the disease and its impact on individuals and families.

By designating September 2023 as "Sickle Cell Disease Awareness Month," the bill aims to promote education and understanding of the disease, as well as the importance of early detection and effective treatment. It also calls for the development of preventative care programs to help manage complications related to sickle cell disease. Overall, Bill 118 HRES 692 seeks to bring attention to the challenges faced by individuals living with sickle cell disease and to encourage efforts to improve research, treatment, and care for those affected by the condition.